HRMY FY 2022 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$438M+43.4% YoY

Gross Profit

$354M80.9% margin

Operating Income

$120M27.4% margin

Net Income

$181M41.4% margin

EPS (Diluted)

$2.97

Cash Flow

Operating Cash Flow

$144M

Free Cash Flow

$144M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$674M

Total Liabilities

$271M

Stockholders' Equity

$403M

Cash & Equivalents

$244M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$438M	$305M	+43.4%
Gross Profit	$354M	$250M	+41.8%
Operating Income	$120M	$88M	+37.3%
Net Income	$181M	$35M	+424.5%